Search

everythinglearnresearchcommunity

for

Search:↓

IVL-DrugFluidic® can mass-produce high-quality, long-acting injectable drug microspheres, improving patient compliance and reducing side effects.

A new mix of anthralin and calcipotriene might help treat severe hair loss.

A 27-year-old with APS-1 showed improvement in symptoms after treatment.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

Researchers found a new mutation in the HR gene linked to a rare hair loss condition.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition with inflammation and scarring, resembling but distinct from common balding.

Sodium citrate causes less pain than acid citrate dextrose-A in PRP therapy.

The STRIAA tool helps doctors quickly and effectively assess the severity of Alopecia Areata.

IVIg treatment improved symptoms but caused permanent dark hair loss.

Fibrosing alopecia in a pattern distribution is a new type of scarring hair loss that resembles common baldness and an autoimmune skin disease.

The new delivery system improves Alzheimer's symptoms by releasing Huperzine A slowly and effectively.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

SII is a useful and affordable tool to assess and monitor alopecia areata.

A protein called PLC2 is important for the growth and development of plant roots influenced by auxin.

Ayurvedic treatment successfully managed alopecia areata without side effects.

The session covered updates on skin treatments, including radiotherapy, imiquimod, acitretin, JAK inhibitors, and strategies for managing rosacea and preventing surgical infections.

The ACP's migraine treatment guidelines are flawed and don't prioritize patient safety.

Experts created guidelines for who in Australia can get subsidized JAK inhibitor therapy for alopecia areata.

A rare endocrine disorder, APS 1, was diagnosed in a 26-year-old man in Bangladesh.

Certain genetic markers, especially the MICA gene, are linked to alopecia areata.

A new topical treatment may prevent hair loss from cancer therapy by adjusting cell death processes in hair follicles.

Baricitinib significantly improves hair regrowth in severe alopecia areata.

Pegylated interferon-alpha 2a can cause a rare nerve disorder, but early treatment can lead to full recovery.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

ADF8 and ADF11 help root hairs grow by responding to hormones and environmental signals.

The new microneedle patch effectively treats alopecia areata with fewer side effects than oral medication.

FFA and FAPD might be related or stages of the same disease.

Mixed coconut oil/solvent is suitable for cyproterone acetate injections, but more safety checks are needed.

A JAK1 variant causes hair loss, skin issues, and thyroid disease, but treatment with a specific inhibitor can help.